Competing risk of death and end-stage renal disease in incident chronic kidney disease (stages 3 to 5): the EPIRAN community-based study
Crossref DOI link: https://doi.org/10.1186/s12882-016-0379-3
Published Online: 2016-11-15
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ayav, Carole
Beuscart, Jean-Baptiste
Briançon, Serge
Duhamel, Alain
Frimat, Luc
Kessler, Michèle
Funding for this research was provided by:
a public funding through a Hospital Clinical Research Program (PHRC 2002).
License valid from 2016-11-15